This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Burn of other parts of eye and adnexa눈 및 부속기 기타 부분의 화상 (안구 부속기 화상)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: T26.3 (burn of other parts of eye and adnexa) | Special Copayment Reduction: V305 (special copayment reduction for severe burns, category 3, inpatient: hospitalization and surgery for third-degree burns of the face, genitalia·perineum, hands, feet or eyeball; 5% copayment for 1 year from the registration date)
B. SynonymsOcular adnexal burn, lacrimal apparatus burn, Lacrimal apparatus burn, Optic nerve burn, Orbital burn, Burns of other specified parts of eye and adnexa
C. Adult onsetBurns involving other ocular adnexa besides the eyelids, cornea and conjunctiva, such as the lacrimal apparatus, sclera, optic nerve and orbit, accompanied by complex functional impairment and reconstructive challenges depending on the site.
1. HistoryRecognition and treatment of lacrimal, orbital and optic nerve burns were systematized in the 20th century after ophthalmology became specialized.
2. CausesThe periorbital region, lacrimal apparatus, sclera and optic nerve are injured by flame, chemicals, electricity or radiation.
3. GeneticsNo direct genetic cause; gene polymorphisms related to tissue regenerative capacity affect adnexal recovery.
4. General epidemiologyT26.3 is a residual category code that includes burns of other ocular adnexa such as the lacrimal apparatus, optic nerve and orbit; incidence is low but clinical importance is high.
5. PathophysiologySite-specific burn mechanisms; cicatricial stenosis with lacrimal injury, irreversible vision loss with optic nerve injury.
6. SymptomsSite-specific symptoms; epiphora with lacrimal injury, visual field defects·blindness with optic nerve injury, impaired eye movement with orbital burns.
7. SignsLacrimal stenosis, optic disc edema or pallor, exophthalmos or enophthalmos, restricted eye movement.
8. ScreeningLacrimal irrigation, orbital CT/MRI, visual evoked potential testing, visual field testing.
9. DiagnosisClinical·imaging diagnosis; assessment of site-specific functional impairment, consultation with relevant specialties.
10. TreatmentSite-tailored treatment; lacrimal duct reconstruction, orbital decompression, optic nerve protective therapy.
11. PrognosisPrognosis varies greatly by site; optic nerve injury is irreversible, lacrimal injury can be corrected surgically.
12. PreventionChemical safety goggles, face shields, radiation shielding, safety education.
13. ReferencesSharma N et al. Treatment of acute ocular chemical burns … and 9 other papers

1. History

Burns of other parts of the eye and adnexa (T26.3) include burns of all eye-related structures other than the eyelid (T26.0), cornea·conjunctiva (T26.1) and destruction of the eyeball (T26.2) — the lacrimal apparatus, sclera, uvea, optic nerve and orbit. Medical recognition and treatment advances for each of these structures date from the mid-19th century onward, when ophthalmology began to become independent as a specialty.

Systematic treatment of lacrimal apparatus burns became possible in the early 20th century with the development of dacryocystorhinostomy (DCR). The DCR procedure, first described by Addeo Toti in 1904, has undergone many refinements and is still used today as the standard operation for correcting lacrimal duct stenosis. Understanding of optic nerve burns and radiation injury deepened in the 20th century along with research on radiation exposure in the nuclear age and on adverse effects of radiotherapy for head and neck cancer. Complex reconstructive surgery for orbital burns was established in the late 20th century with the development of oculoplastic surgery, and has now reached the point where customized reconstruction using image-guided surgery and 3D printing is possible.


2. Causes

The causes of burns of other ocular adnexa included in T26.3 vary with the site involved. Lacrimal apparatus burns: the lacrimal punctum, canaliculi and lacrimal sac are injured by chemical contact at the medial canthus or direct extension of facial burns. In some cases an alkali burn travels retrogradely through the lacrimal drainage system and injures the lacrimal sac mucosa. Scleral·uveal burns: deep penetration of chemicals or high heat from electrical burns can extend injury to the sclera and uvea (iris, ciliary body, choroid). Optic nerve burns: radiation optic neuropathy after radiotherapy and optic nerve injury from electrical burns have been reported. Orbital burns: explosions·scalds cause direct injury to periorbital tissues (orbital fat, extraocular muscles, orbital periosteum).


3. Genetics

Burns of other parts of the eye and adnexa are acquired injuries in themselves and have no direct genetic cause. However, genetic factors indirectly affect the recovery capacity of each site. Polymorphisms of growth factor receptor genes involved in lacrimal epithelial regeneration (EGF receptor, FGFR, etc.) influence the degree of lacrimal duct stenosis and the likelihood of spontaneous recovery. Studies suggest that expression levels of the SIRT1, BDNF (Brain-derived neurotrophic factor) genes, involved in nerve regeneration capacity after optic nerve injury, may affect the likelihood of optic nerve recovery.

The regenerative capacity and fibrotic tendency of orbital fat tissue are related to differences in TGF-β and PPAR-γ gene expression. The risk of radiation optic neuropathy is related to variants of radiosensitivity genes (ATM, BRCA1/2, etc.), so genetic risk assessment is becoming increasingly important in head and neck radiotherapy.


4. General epidemiology

T26.3 is the residual category code in ICD-10 assigned to burns of the remaining ocular adnexa, excluding the eyelid (T26.0), cornea·conjunctiva (T26.1), destruction of the eyeball (T26.2) and unspecified site (T26.4). The lacrimal, scleral, uveal, optic nerve and orbital burns included in this category are each infrequent, but clinically each causes important functional impairment. Among facial burn patients, lacrimal injury from burns of the medial canthal region occurs in about 5~10%, subsequently leading to lacrimal duct stenosis and chronic epiphora.

Radiation optic neuropathy is reported in about 0.5~8% of patients who received radiotherapy for head and neck cancer, and the risk increases markedly at radiation doses of 60 Gy or more. Optic nerve injury from electrical burns is not uncommonly reported in patients with high-voltage electrical accidents. Patients with these burns of other ocular adnexa are eligible for support under special copayment reduction V305 and require a multidisciplinary approach at a specialized ophthalmology center.


5. Pathophysiology

The burn mechanism of each structure covered by T26.3 differs by site. Lacrimal apparatus burns: chemicals penetrate into the lacrimal drainage system through the medial canthal punctum, or burn scarring at the medial canthus compresses the canaliculi. In alkali burns, liquefactive necrosis of the lacrimal duct mucosa occurs, and cicatricial stenosis progresses during healing. Scleral burns: deep penetration of chemicals or electrical·thermal injury causes collagen lysis and fibrosis. Scleral necrosis increases the risk of ocular hypotony and infection.

Optic nerve burns: in radiation injury, impaired optic nerve blood flow due to vascular endothelial cell damage causes ischemic injury to the optic nerve fibers. Electrical injury occurs through direct thermal injury from the formation of current pathways within the optic nerve, or through thrombus formation. Irreversible damage to the optic nerve cell bodies (retinal ganglion cells) cannot be recovered even with treatment. Orbital burns: inflammation and fibrosis of the intraorbital fat tissue compress the posterior globe, causing exophthalmos or orbital inflammation.


6. Symptoms

Symptoms of T26.3 vary with the structure involved. Lacrimal injury: in the acute phase there is medial canthal swelling and pain, and in the chronic phase persistent tearing (epiphora) is the main symptom. When lacrimal sac infection (dacryocystitis) accompanies it, purulent discharge appears together with medial canthal redness·swelling·tenderness. Scleral injury: as scleral blanching (scleral ischemia) progresses, eye pain and injection develop, and in severe cases there is a risk of globe perforation due to scleral melt.

Optic nerve injury: visual field defects, afferent pupillary defect (APD) and color vision abnormalities appear, and in severe cases complete blindness occurs. Radiation optic neuropathy often presents with sudden vision loss months~years after radiotherapy. Orbital injury: exophthalmos or enophthalmos, diplopia, restricted eye movement and eye pain appear.


7. Signs

On clinical examination, the characteristic signs for each structure are as follows. Signs of lacrimal stenosis: reflux of saline on lacrimal irrigation, reflux of purulent discharge on pressure over the lacrimal sac. Signs of scleral burns: scleral blanching (ischemic whitening of sclera), loss of scleral vessels, possible uveal exposure at sites of scleral necrosis. Signs of optic nerve burns: afferent pupillary defect (APD), optic disc edema or pallor (optic atrophy) on fundus examination, central scotoma or hemianopia on perimetry. Signs of orbital burns: proptosis, restricted eye movement due to extraocular muscle dysfunction, increased proptosis on Hertel exophthalmometry.


8. Screening

Assessment of T26.3 requires tests tailored to the site involved. Lacrimal assessment: lacrimal irrigation, dacryocystography and CT dacryocystography evaluate the site and degree of lacrimal duct stenosis. Assessment of the sclera·posterior globe: ocular ultrasonography (B-scan) evaluates posterior globe structures, and orbital CT·MRI confirm the extent of injury to intraorbital tissues and the optic nerve. Assessment of optic nerve function: visual field testing (automated perimetry), visual evoked potentials (VEP), optical coherence tomography (OCT) analysis of retinal nerve fiber layer thickness, and fundus photography are used. Color vision testing (Ishihara, Farnsworth-Munsell 100 hue test) is a sensitive indicator of optic nerve injury.


9. Diagnosis

Diagnosis of burns of other ocular adnexa covered by T26.3 is in principle a clinical·imaging diagnosis by an ophthalmologist. Because ICD-10 T26.3 is a residual code applied to burns of the eye and adnexa not covered by T26.0~T26.2, it is important to specify the exact anatomical site in the diagnostic record. The cause of the burn (chemical, thermal, electrical, radiation) and the mechanism of exposure are accurately identified and recorded.

If lacrimal injury is suspected, ophthalmic lacrimal irrigation is performed, and according to the site of stenosis, canalicular vs. lacrimal sac vs. nasolacrimal duct stenosis is differentiated. When optic nerve injury is suspected, neuro-ophthalmology consultation is needed, and if there is a history of radiotherapy, radiation optic neuropathy is differentiated from optic nerve burns. If orbital involvement is suspected, oculoplastics consultation and CT/MRI imaging are needed.


10. Treatment

Treatment of lacrimal apparatus burns: in the acute phase, ophthalmic emergency treatment (irrigation, antibiotics, steroids) is performed. If lacrimal duct stenosis develops, dacryocystorhinostomy (DCR) is the standard treatment, and endoscopic DCR is preferred as a minimally invasive method. Canalicular stenosis is treated with silicone tube insertion or canaliculoplasty.

Treatment of scleral burns: if scleral necrosis develops, the sclera is covered with a conjunctival flap, amniotic membrane graft or scleral graft to protect the intraocular structures. Treatment of optic nerve burns: high-dose steroids (methylprednisolone) for acute optic nerve injury may be effective in some patients, but there is no definitive treatment for radiation optic neuropathy. Anti-VEGF agents and hyperbaric oxygen therapy are tried as adjuncts. Treatment of orbital burns: orbital decompression is performed when the globe is compressed by increased intraorbital pressure, and orbital reconstruction aims at restoring extraocular muscle function and replacing volume.


11. Prognosis

The prognosis of burns of other ocular adnexa covered by T26.3 varies greatly with the site involved and the degree of injury. Lacrimal injury can mostly regain function with appropriate surgical treatment (DCR, etc.), with reported surgical success rates of about 80~95%. Scleral injury in severe cases may make preservation of the globe itself difficult, but with early treatment ocular function can be preserved. Optic nerve injury is the site with the poorest prognosis; because of the irreversibility of nerve cells, recovery of damaged optic nerve function is limited, and in severe cases permanent visual field defects or blindness remain.

Orbital injury allows some recovery of eye movement function and appearance through appropriate reconstructive surgery, but with severe orbital fibrosis, diplopia and exophthalmos may remain as long-term complications. Because reduced quality of life from visual impairment increases psychological morbidity, participation in vision rehabilitation programs and mental health support contribute to a better prognosis.


12. Prevention

Prevention of burns of other ocular adnexa follows the general principles for preventing facial·ocular burns. Wearing chemical safety goggles and a face shield is the most effective means of prevention. In particular, side-sealed goggles are needed to protect the medial canthal region adjacent to the lacrimal apparatus. In head and neck cancer patients receiving radiotherapy, the radiation dose to the optic nerve and lacrimal gland is minimized through radiation shielding techniques and optimization of radiation planning.

Electrical workers wear insulated gloves and face shields and follow additional safety measures when working on high-voltage electrical equipment. When a chemical contacts the face, immediate irrigation and an emergency ophthalmology visit are key to secondary prevention. Especially when a chemical contacts the medial canthal region, immediate irrigation is very important to prevent penetration into the lacrimal duct.


13. References

  1. Sharma N, Kaur M, Agarwal T, Sangwan VS, Vajpayee RB. Treatment of acute ocular chemical burns. Survey of Ophthalmology. 2018;63(2):214-235. DOI: 10.1016/j.survophthal.2017.09.005. PMID: 28935121.

  2. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. British Journal of Ophthalmology. 2001;85(11):1379-1383. DOI: 10.1136/bjo.85.11.1379. PMID: 11673310.

  3. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999;106(7):1268-1277. DOI: 10.1016/S0161-6420(99)00707-1. PMID: 10406608.

  4. Levin LA, Daniels AB. Radiation-induced optic neuropathy. Seminars in Ophthalmology. 2018;33(1):74-80. DOI: 10.1080/08820538.2017.1377860. PMID: 28692386.

  5. Bartley GB, Liesegang TJ. Lacrimal drainage system. Ophthalmology Clinics of North America. 1995;8:463-476.

  6. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Survey of Ophthalmology. 1997;41(4):275-313. DOI: 10.1016/s0039-6257(96)00007-0. PMID: 9104770.

  7. Eslani M, Baradaran-Rafii A, Movahedan A, Djalilian AR. The ocular surface chemical burns. Journal of Ophthalmology. 2014;2014:196827. DOI: 10.1155/2014/196827. PMID: 25105013.

  8. Kuckelkorn R, Schrage N, Keller G, Redbrake C. Emergency treatment of chemical and thermal eye burns. Acta Ophthalmologica Scandinavica. 2002;80(1):4-10. DOI: 10.1034/j.1600-0420.2002.800102.x. PMID: 11906302.

  9. Morin JD, Cobb CJ. Scleral necrosis: review of the literature and case report. Canadian Journal of Ophthalmology. 1977;12(1):35-42. PMID: 319038.

  10. Rowan MP, Cancio LC, Elster EA, et al. Burn wound healing and treatment: review and advancements. Critical Care. 2015;19:243. DOI: 10.1186/s13054-015-0961-2. PMID: 26060988.